CN112641637B - 一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 - Google Patents
一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 Download PDFInfo
- Publication number
- CN112641637B CN112641637B CN202011534396.XA CN202011534396A CN112641637B CN 112641637 B CN112641637 B CN 112641637B CN 202011534396 A CN202011534396 A CN 202011534396A CN 112641637 B CN112641637 B CN 112641637B
- Authority
- CN
- China
- Prior art keywords
- layer
- heating
- mask
- liquid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010438 heat treatment Methods 0.000 title claims abstract description 86
- 239000000835 fiber Substances 0.000 title claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 206010000496 acne Diseases 0.000 title claims abstract description 29
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 26
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 23
- 235000010443 alginic acid Nutrition 0.000 title claims abstract description 22
- 229920000615 alginic acid Polymers 0.000 title claims abstract description 22
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 229940072056 alginate Drugs 0.000 title claims abstract description 18
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 17
- 238000001879 gelation Methods 0.000 title claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 71
- 230000001815 facial effect Effects 0.000 claims abstract description 51
- 238000002955 isolation Methods 0.000 claims abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 20
- 238000002844 melting Methods 0.000 claims abstract description 5
- 230000008018 melting Effects 0.000 claims abstract description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 62
- 239000000661 sodium alginate Substances 0.000 claims description 62
- 229940005550 sodium alginate Drugs 0.000 claims description 62
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 61
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 50
- 239000001110 calcium chloride Substances 0.000 claims description 48
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 48
- 239000004745 nonwoven fabric Substances 0.000 claims description 20
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical group OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 18
- 239000000654 additive Substances 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- -1 polyethylene Polymers 0.000 claims description 11
- 239000004698 Polyethylene Substances 0.000 claims description 9
- 229920000573 polyethylene Polymers 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 6
- 230000003385 bacteriostatic effect Effects 0.000 claims description 6
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 6
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 6
- 229960002227 clindamycin Drugs 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 4
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 241001474374 Blennius Species 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000008236 heating water Substances 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 24
- 230000000694 effects Effects 0.000 description 16
- 235000010410 calcium alginate Nutrition 0.000 description 10
- 239000000648 calcium alginate Substances 0.000 description 10
- 229960002681 calcium alginate Drugs 0.000 description 10
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 6
- 229910001424 calcium ion Inorganic materials 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012943 hotmelt Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000429 sodium aluminium silicate Substances 0.000 description 1
- 235000012217 sodium aluminium silicate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F7/03—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/02—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions
- B32B3/08—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions characterised by added members at particular parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/26—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layer; characterised by a layer with cavities or internal voids ; characterised by an apertured layer
- B32B3/266—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layer; characterised by a layer with cavities or internal voids ; characterised by an apertured layer characterised by an apertured layer, the apertures going through the whole thickness of the layer, e.g. expanded metal, perforated layer, slit layer regular cells B32B3/12
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
- B32B5/022—Non-woven fabric
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B9/00—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B9/00—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00
- B32B9/04—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material
- B32B9/045—Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0003—Face
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0203—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor
- A61F2007/0206—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor containing organic solids or fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0225—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
- A61F2007/0226—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof adhesive, self-sticking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0244—Compresses or poultices for effecting heating or cooling with layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0268—Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Ceramic Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Textile Engineering (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明属于卫生健康领域,尤其涉及抑制痤疮自发热吸水凝胶化的海藻纤维面膜,该面膜包括面膜基材和面膜液,面膜至少为四层结构,包括发热层、隔离层、多孔渗液层和凝胶层;在隔离层的一侧设置有发热层,隔离层的另一侧设置有凝胶层;在发热层背离隔离层的方向设置有多孔渗液层;多孔渗液层和隔离层均通过热熔连接在一起,并构成一个独立隔离的空间,所述的发热层被多孔渗液层和隔离层构成的空间包覆。面膜液为使用过程中,只需加面膜液或者水,遇水能够发热,能够有效的提高使用舒适度。
Description
技术领域
本发明属于纤维材料领域,是一种卫生健康用品纺织材料,具体涉及一种自发热海藻纤维凝胶面膜。
背景技术
海藻酸是一种从海藻中提取出的天然多糖,具有良好的生物兼容性,并且降解性能优异,使用该天然多糖能制备成海藻酸纤维,主要是通过海藻酸钠与钙进行离子交换,所制备得到的海藻酸纤维具有优异的吸液保湿性能,由于海藻酸具有良好的生物兼容性、吸湿保湿,该天然多糖纤维在医疗和纺织卫生领域有广泛的应用。
正常皮肤的角质层含水率为10~30%,当外界环境变化(比如风吹、日晒、寒冷等),加上日常电脑辐射等因素,人们生活节奏和压力加大,很多人出现了各种皮肤问题。因此,消费者们对于肌肤的护理需求也日益增长,对于肌肤的护理已有最开始的保湿滋养,到现在的兼顾与保湿滋养的同时还要求舒适性。而在卫生健康领域,对于肌肤护理产品,如面膜材料,要求面膜材料具有较高的吸湿保湿性能,而目前对于面膜的制备,大多都关注与添加剂、保湿剂、精华等方面的改进。
现有技术中,如公开号为CN111588679A,发明名称为一种保湿护肤面膜及其制备工艺,其公开了为了解决面膜锁水性较差,而导致皮肤应后容易引起小细纹,带来肌肤弹润性下降的问题,其提供了一种面膜液,包括去离子水;甘油;丁二醇;甜菜碱;丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物;丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物;蔗糖硬脂酸酯;山嵛醇;聚山梨醇酯-60;甲基葡糖醇聚醚-10;薏苡仁籽提取物,同时该面膜中还包括了海藻酸纤维,可见,现有技术中,对于面膜的研究主要集中在对于面膜液等的研究,而海藻酸纤维仅仅是一种普通的纤维基体的添加,这类面膜虽然可以解决吸液保湿的性能,但是在使用过程中,还是存在液体过多,舒适度欠佳的问题。
另外,现有技术还公开了一种抑制痤疮的面膜,具体的,公开号为:CN111202709A,发明名称为:一种能够抑制痤疮丙酸杆菌的乳酸菌面膜及制备方法,具体的公开了面膜液及制备方法;包括:5份丙二醇,2份PEG-40氢化蓖麻油,1.4份透明质酸钠,2份甘草酸二甲,0.2份卡波姆,0.1份羟乙基纤维素,0.2份氯苯甘醚,0.05份香叶天竺葵油,0.2份苯氧乙醇,2.1份三乙醇胺,0.5份菊粉,0.84份灭活冻干粉,余量水。该发明使用了灭火冻干粉,冻干粉中具有鼠李糖乳杆菌LR863,其含有乳酸、乙酸和细菌素等抑菌物质和活性成分,能够在抑制痤疮丙酸杆菌的同时起到修复皮肤屏障的作用,从而达到祛除痤疮的效果。
针对现有技术中面膜的使用不舒服,尤其是冬天面膜在吸液后,面膜温度较低,在使用时候,对面膜的刺激较大,因此,本发明旨在提供一种使用舒适的,吸液能够凝胶化的,可自发热的面膜,以提高面膜在使用过程的舒适性能。同时,现有技术中的面膜主要是给皮肤补水,改善皮肤的机能,对于存在一定皮肤问题的消费者,更需要一种能够改善皮肤质量的面膜液,本发明面膜还配备了一种面膜液,该面膜液主要是针对目前痤疮治疗主要以口服抗菌药物、激素、维A酸类药物及外用消炎药为主,疗程比较长、病情易复发、且易产生不良反应等问题,而且易形成瘢痕或色素沉着。该面膜液具有抑制痤疮效果,减少消费者面部肌肤的瘢痕形成或色素沉着。
发明内容
本发明旨在制备一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,该面膜是一种干态面膜,在使用时,该面膜需要加入水或面膜液,该面膜在吸水后能够自然发热,同时面膜能够凝胶化,具有优异的吸水和保湿性能,在使用过程中,由于面膜具有自发热功能,消费者使用舒适度会极大提高。
具体的,本发明的构思是在于通过对面膜的结构进行合理的设计,保证面膜上发热组分能够适当的发热,同时防止发热组分与水反应的产物扩散,影响使用。
进一步的,本发明的构思还在于提供了一种面膜液,该面膜液具有天然生物肽材料和抑菌的活性成分。
抑菌活性成分具有抑制痤疮丙酸杆菌的生长,而天然生物肽组分容易渗透到角质层、真皮层,从一定程度上防止黑色素的形成,减少色素沉着,除此之外还有抗紫外线以及抗氧化的功效。
具体的本发明所提供的一种自发热吸凝胶化面膜,其特征在于,该面膜具有一层发热层,所述的发热层吸水能够自发热,所述发热层包括氯化钙和海藻酸钠,所述的氯化钙和海藻酸钠的比例为1:20-50。
本发明所提供的面料中使用氯化钙和海藻酸钠作为添加料,其中,当发热层遇水后,氯化钙会与水反应快速释放热量,进而提高水的温度,提高人们使用体验。另外,海藻酸钠吸水也会发生凝胶化,而高温会使得海藻酸钠加速的凝胶化,同时海藻酸钠的量比氯化钙的占比多,因此,海藻酸钠所形成的凝胶可以快速的将氯化钙包覆,从而减缓水分向氯化钙的扩散,进而控制热量的产生,通过海藻酸钠的使用,控制了氯化钙遇水发热的速率,达到缓释反应的作用。
同时,氯化钙在与水的反应过程中,会产生氯化钙,在水体系的条件下,氯化钙能够与的海藻酸钠发生离子交换反应,生成海藻酸钙材料,而海藻酸钙是一种不溶于水的材料,该材料能够将未反应完全的氯化钙发生包覆,进而控制氯化钙的反应速度,防止水分温度升高过快,影响消费者使用体验,同时,通过本发明的结构设计,可以使得面膜发热过程具有一定持续性。同时,本发明使用的海藻酸钠成分较多,海藻酸钠的凝胶化,可以将生成的氯化钙进行锁定,防止氯化钙也液体中的扩散,对人体皮肤产生刺激。
进一步的,所述的发生层是以纤维组成的无纺布作为为基体材料,发热添加料是附着在基体材料上。
进一步的,发热层还可以包括硅铝酸钠,即为沸石。
沸石在溶液中也会产生热量,该热量的产生主要是因为沸石具有多孔结构,在见水后能够剧烈的吸附液体,进而产生热量,达到放热的效果。
进一步的,所述的沸石占氯化钙和海藻酸钠重量的0-20%。
优选的,所述的基体材料为海藻酸钠纤维无纺布。
所述所述的海藻酸钠纤维无纺布的制备方法是将海藻酸钙纤维通过针刺工艺制备成海藻酸钙无纺布,所制备得到的海藻酸钙无纺布快速经过氯化钠的溶液,将海藻酸钙转换成海藻酸钠,海藻酸钠纤维在吸水后,能够凝胶化,进而锁定氯化钙,防止氯化钙的流动。
进一步的,所述发热添加料通过喷涂方式添加到海藻酸钠纤维基体上。
进一步的,为了防止所产生的氯化钙与皮肤接触,本发明的材料还有一层隔离层,该隔离层设置在发热层的下方,该隔离层是一种不透湿的材料,如聚乙烯薄膜。
该隔离层能够有效的防止氯化钙所产生的氯化钙溶液的渗透,防止氯化钙向皮肤的扩散。
进一步的,为了更加有效的防止氯化钙的渗透,本发明在所述隔离层和所述的发热层之间还设置有一层海藻酸钠纤维无纺布的溢液锁定层。
所述的溢液锁定层主要是锁定多余液体,防止多余液体向下渗透。
进一步的,所述的发热层上方还设置一层多孔渗液层,该多孔渗液层是多孔薄膜,所述薄膜为聚乙烯薄膜。
具体的,该多孔渗透层上具有均匀分布的孔洞,该孔洞的大小为1-2mm。
所述多孔渗液层主要是在使用过程中,控制水分向面膜发热层的渗透,通过多孔的孔隙率,可以控制水分的渗透速率,同时,多孔渗透层还有利于氯化钙发热的热量的锁定,延长面膜的保温时长。
进一步的,所述的隔离层另一层为凝胶无纺布层,所述凝胶无纺布为吸水可凝胶纤维,该吸水可凝胶纤维能够高效锁定水分。
所述的凝胶无纺布为海藻酸钙纤维和/或海藻酸钠纤维混纺无纺布。
所述海藻酸钠在吸水后能迅速凝胶化,形成性能凝胶层。
所述的凝胶层能够锁定水分,该凝胶层与皮肤接触,可以长时间的为皮肤提供更多水分。
进一步的,本发明面膜通过高温剪裁,在剪裁过程中可以使得面膜上层的多孔薄膜和隔离层进行热熔连接。
在制备过程中,由于采用高温剪裁,使得多孔渗液层和隔离层可以热熔连接,该热熔连接后的空间将发热层和溢液锁定层固定在该空间内,当液体浸入到该空间后,发热层中的氯化钙预热会产生热量,同时海藻酸钠粉体会发生溶胀凝胶化,将氯化钙进行锁定,并控制氯化钙的发热速率。而氯化钙与水反应(水解)得到的氯化钙溶液首先会与海藻酸钠发生离子反应,钙被固着,同时溢液锁定层在吸水后能够凝胶化,可以将为被固着的氯化钙溶液进一步锁定。进一步的,本发明的隔离层还会隔离开发热空间内的液体流向凝胶层,对于发热层产生的少量氯化钙可以起到充分的隔离。而在隔离层的另一层是吸水凝胶化的纤维层,该层为包括海藻酸钠纤维,在纤维吸水后,能够凝胶化,吸液量大,同时能够长时间锁定水分,减少水分的流散。
进一步的,所述的面膜为干态面膜,在使用过程中需要配合水或面膜液使用。
具体的,一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜的使用方法如下,将面膜液施加到面膜上,面膜的多孔渗液层会缓慢的将含水液体导入到发热层,发热层中的海藻酸钠会发生吸液膨胀,并成为浓稠液体,同时氯化钙也会遇液发生反应,并产生大量热量,海藻酸钠形成的溶液会控制氯化钙与水分的接触,进而控制热量的产生速度,同时海藻酸钠还会锁定产生的氯化钙,防止碱性液体的扩散,避免皮肤接触到氯化钙。另外,在发热层下还有一层渗液锁定层,该渗液锁定层为海藻酸钠纤维组成的无纺布,该层吸液后也会发生溶胀,对由发热层所渗漏下的液体进行锁定,同时在由多孔渗液层和隔离层组成的空间内,由于具有大量的海藻酸钠材料,该材料能够与钙离子交换,进一步,全方位的锁定钙离子,防止钙离子与皮肤的接触。在隔离层的下方,还有一层吸水凝胶层,该层包括海藻酸钠纤维,该层洗手面膜液后,具有较好的吸液性能,能够锁定水分,滋养皮肤。
进一步的,本发明还提供了一种抑制痤疮的面膜液,具体的,包括天然生物肽和抑菌活性成分。
进一步的所述面膜液还包括了增稠剂、多元醇、透明质酸钠和水。
外源性高浓度、高分子量的透明质酸可以使伤口组织结构疏松,有利于巨噬细胞、成纤维细胞等修复细胞进入伤口组织,从而加速上皮细胞对创面的覆盖、促进伤口组织的愈合进程。
进一步的,所述增稠剂为羟乙基纤维素、卡波姆、黄原胶中的一种或多种。
进一步的,所述的多元醇为戊二醇、丁二醇中的一种或两种。
进一步的所述天然生物肽为鱼皮胶原蛋白肽、猪皮胶原蛋白肽中的一种或两种。
进一步的,所述抑菌活性成分为苯甲醇和克林霉素的组合物。
进一步的,所述的苯甲醇和克林霉素的比例为(5-7):1。
进一步的,所述的面膜液的组分为增稠剂0.1-0.5份,多元醇1-3份,透明质酸0.1-0.5份,抑菌活性成分1-2份,天然生物肽0.5份,余量为水。
本发明所提供的抑制痤疮自发热吸水凝胶化的海藻纤维面膜,该面膜设置有发热层,发热层主要是利用氯化钙的遇水后发热性能,同时考虑到氯化钙反应会产生氯化钙,本发明通过设置隔离层,将发热层与面膜凝胶层实行分离,同时本发明还进一步的在发热层下部设置了凝胶层,该凝胶层在吸液后,体积会大幅度的提高,也能防止所产生的氯化钙向下渗透。因此,本发明所提供的面膜相对于现有技术而言,在使用过程中,遇水能够发热,能够有效的提高使用舒适度。
附图说明
图1:本发明实施例3面膜的结构图;
图2、本发明实施例3面膜的截面图;
1、多孔渗液层;2、孔洞;3、第一溢液锁定层;4、第二溢液锁定层;5、发热层;6隔离层;7、凝胶层;8、面膜边界。
具体实施例
为了进一步验证本发明所达到的效果和解决的问题,本发明公开以下实施例。
实施例1
一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,面膜的最上层为多孔渗液层1,该多孔渗液层为聚乙烯薄膜,该多孔渗透层上具有均匀分布的孔洞2,该孔洞的大小为1-2mm。在多孔渗液层的下一层为发热层5,该发热层的基体为海藻酸钠纤维,该海藻酸钠纤维上具有发热添加剂,发热添加剂为氯化钙和海藻酸钠粉体,其中海藻酸钠与氯化钙的比例为20:1。在发热层下还设置有一层溢液锁定层,该溢液锁定层为海藻酸钠纤维组成的无纺布。在该渗液锁定层的下层设置有隔离层6,该隔离层为聚乙烯薄膜,该隔离层能够将其上下两面的液体隔离,该隔离层与面膜最上层的多孔渗液层热熔连接,该隔离层与多孔渗液层所组成的空间中包括了发热层和溢液锁定层。在隔离层下方设置有凝胶层7,该凝胶层包括有海藻酸钠纤维。
实施例2
一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,面膜的最上层为多孔渗液层1,该多孔渗液层为聚乙烯薄膜,该多孔渗透层上具有均匀分布的孔洞2,该孔洞的大小为1-2mm。在多孔渗液层的下一层为发热层5,该发热层的基体为海藻酸钠纤维,该海藻酸钠纤维上具有发热添加剂,发热添加剂为氯化钙和海藻酸钠粉体,其中海藻酸钠与氯化钙的比例为30:1。在该发热层的下层设置有隔离层6,该隔离层为聚乙烯薄膜,该隔离层能够将其上下两面的液体隔离,该隔离层与面膜最上层的多孔渗液层热熔连接,该隔离层与多孔渗液层所组成的空间中包括了发热层和溢液锁定层。在隔离层下方设置有凝胶层7,该凝胶层包括有海藻酸钠纤维。
实施例3
一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,面膜的最上层为多孔渗液层1,该多孔渗液层为聚乙烯薄膜,该多孔渗透层上具有均匀分布的孔洞2,该孔洞2的大小为1-2mm。在多孔渗液层的下一层第一溢液锁定层3,在第一溢液锁定层下方设置发热层5,该发热层的基体为海藻酸钠纤维,该海藻酸钠纤维上具有发热添加剂,发热添加剂为氯化钙和海藻酸钠粉体,其中海藻酸钠与氯化钙的比例为20:1。在发热层下还设置有第二溢液锁定层4,该溢液锁定层为海藻酸钠纤维组成的无纺布。在该第二渗液锁定层的下层设置有隔离层6,该隔离层为聚乙烯薄膜,该隔离层能够将其上下两侧的液体隔离,该隔离层与面膜最上层的多孔渗液层热熔连接,该隔离层与多孔渗液层所组成的空间中包括了发热层5和两层溢液锁定层。在隔离层6下方设置有凝胶层7,该凝胶层7包括有海藻酸钠纤维。
实施例4
本发明实施例1所提供的一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜的制备方法,其中,包括如下步骤,步骤(1),制备海藻酸钠纤维无纺布,首先将海藻酸钙纤维经过针刺,制备成海藻酸钙无纺布,将海藻酸钙无纺布通过氯化钠溶液,发生离子交换,将海藻酸钙转换成海藻酸钠,之后将该无纺布通过酒精溶液进行脱水,酒精置换脱水后进行干燥,得到海藻酸钠无纺布。步骤(2),通过喷涂的方式,将发热添加剂加入到该海藻酸钠无纺布上,得到发热层织物。步骤(3)将多孔多孔渗液层、发热层、溢液锁定层、隔离层、和凝胶层依次叠加。步骤(4),通过热熔剪裁的方式,将步骤(3)的叠层织物剪裁成面膜形状,由于高温效果,多孔渗液层和隔离层会发生热熔,形成热压边界8,进而形成一个相对密封空间,最终形成了发热层相对独立的,可自发热的吸水凝胶化的面膜。
实施例5
一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其面膜液的组分为:羟乙基纤维素0.1份,丁二醇1份,透明质酸0.1份,苯甲醇和克林霉素组合物1份,鱼皮胶原蛋白肽0.5份,余量为水,其中苯甲醇和克林霉素的比例为5:1。
实施例6
本发明实施例1所提供的一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜的使用方法如下,将面膜液施加到面膜基材上,面膜的多孔渗液层会缓慢的将含水液体导入到发热层,发热层中的海藻酸钠会发生吸液膨胀,并成为浓稠液体,同时氯化钙也会遇液发生反应(水解),并产生大量热量,海藻酸钠形成的溶液会控制氯化钙与水分的接触,进而控制热量的产生速度,同时海藻酸钠还会锁定产生的氯化钙,防止碱性液体的扩散,避免皮肤接触到氯化钙。另外,在发热层下还有一层渗液锁定层,该渗液锁定层为海藻酸钠纤维组成的无纺布,该层吸液后也会发生溶胀,对由发热层所渗漏下的液体进行锁定,同时在由多孔渗液层和隔离层组成的空间内,由于具有大量的海藻酸钠材料,该材料能够与钙离子交换,进一步,全方位的锁定钙离子,防止钙离子与皮肤的接触。在隔离层的下方,还有一层吸水凝胶层,该层包括海藻酸钠纤维,该层洗手面膜液后,具有较好的吸液性能,能够锁定水分,滋养皮肤。
面膜性能测试:
将实施例5中的面膜液与实施例1中的面膜基材作为配套使用,随机选样60人,年龄20-35岁的人群,其中女性40人,男性20人,每周使用2次面膜,使用时间15-20分钟,使用两个月。统计测试者使用效果,测试效果包括是否过敏、补水效果测评、粉刺痤疮测评。
是否过敏:有:引起不舒服,有刺激感觉;否:没有任何刺激和不适;
补水效果:优:补水效果好于一般面膜;良:和一般面膜相当;差:不如一般面膜;
粉刺痤疮:优:对痤疮和粉刺有明显效果;良:为感觉有有效果;差:无效果。
发热效果:优:发热效果良好,舒适;良:发热过快,温度过高;差:无明显发热效果。
测试统计效果如下:
过敏统计 | 有:0 | 无:60 | |
补水统计 | 优:40 | 良:17 | 差:3 |
粉刺痤疮 | 优:35 | 良:21 | 差:4 |
发热效果 | 优:54 | 良:3 | 差:3 |
从测试效果来看,本发明所制备的面膜具有假面膜液后自发热的功能,测试使用者反应良好,温度适中,使用舒适,同时补水效果也令人满意,对于粉刺痤疮的保养效果,根据两个月的使用统计结果也可以看出,本发明提供过的面膜中加入抗菌成分和天然蛋白肽成分,可以对粉刺和/或痤疮也具有一定的效果。
Claims (5)
1.一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其特征在于:该面膜包括面膜基材和面膜液,所述面膜基材至少为四层结构,包括发热层、隔离层、多孔渗液层和凝胶层;在隔离层的一侧设置有发热层,隔离层的另一侧设置有凝胶层;在发热层背离隔离层的方向设置有多孔渗液层;多孔渗液层和隔离层均通过热熔连接在一起,并构成一个独立隔离的空间,所述发热层被多孔渗液层和隔离层构成的空间包覆;
其中,所述发热层的基体材料为海藻酸钠纤维无纺布,通过喷涂方式将发热添加剂施加到发热层上,所述发热添加剂为海藻酸钠和氯化钙的组合物;
所述发热层包括氯化钙和海藻酸钠;所述海藻酸钠与氯化钙的质量比20-50:1;所述多孔渗液层上还有均匀分布的孔洞,所述孔洞的大小为1-2mm;
所述发热层和隔离层之间设置有第一溢液锁定层;
所述面膜液的组分为增稠剂0.1-0.5份,多元醇1-3份,透明质酸0.1-0.5份,抑菌活性成分1-2份,天然生物肽0.5份,余量为水;
其中,所述增稠剂为羟乙基纤维素、卡波姆、黄原胶中的一种或多种;多元醇为戊二醇、丁二醇中的一种或两种;天然生物肽为鱼皮胶原蛋白肽、猪皮胶原蛋白肽中的一种或两种;抑菌活性成分为苯甲醇和克林霉素的组合物。
2.一种如权利要求1所述的抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其特征在于:所述苯甲醇和克林霉素的比例为(5-7):1。
3.一种如权利要求1所述的抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其特征在于:所述发热层和所述多孔渗液层之间设置有第二溢液锁定层。
4.一种如权利要求1-2任一项所述的抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其特征在于:所述发热层、多孔渗液层和凝胶层的厚度小于1mm。
5.一种如权利要求1所述的抑制痤疮自发热吸水凝胶化的海藻纤维面膜,其特征在于:所述隔离层和多孔渗液层为聚乙烯薄膜制成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011534396.XA CN112641637B (zh) | 2020-12-23 | 2020-12-23 | 一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011534396.XA CN112641637B (zh) | 2020-12-23 | 2020-12-23 | 一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112641637A CN112641637A (zh) | 2021-04-13 |
CN112641637B true CN112641637B (zh) | 2023-02-10 |
Family
ID=75359495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011534396.XA Active CN112641637B (zh) | 2020-12-23 | 2020-12-23 | 一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112641637B (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361700A (zh) * | 2007-08-08 | 2009-02-11 | 秦益民 | 一种含海藻酸纤维的面膜材料、制备方法和应用 |
CN107137239A (zh) * | 2017-03-28 | 2017-09-08 | 南京工业大学 | 一种发热面膜及制备方法 |
CN210991937U (zh) * | 2019-10-09 | 2020-07-14 | 上海科颜生物科技有限公司 | 一种海藻凝胶面膜 |
CN212089922U (zh) * | 2020-03-05 | 2020-12-08 | 云南中医药大学 | 一种舒适卫生的自发热面膜 |
CN111560708B (zh) * | 2020-04-08 | 2021-10-15 | 青岛大学 | 能吸水凝胶化含海藻纤维的水刺织物及其制备方法和应用 |
CN111568918B (zh) * | 2020-06-24 | 2021-11-16 | 华熙生物科技股份有限公司 | 一种治疗炎性痤疮的凝胶组合物及其制备方法 |
-
2020
- 2020-12-23 CN CN202011534396.XA patent/CN112641637B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112641637A (zh) | 2021-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104288828B (zh) | 一种医用生物抑瘢除皱敷料及其制备方法 | |
KR100676937B1 (ko) | 피부미용 및 상처치료용 수용성 필름 및 그 제조방법 | |
CN104173251B (zh) | 一种牦牛骨胶原肽美白面膜及其制备方法 | |
CN105193673B (zh) | 一种清痘修复液及其制备方法 | |
CN105250187A (zh) | 一种植物活性肽紧致面膜精华液及其应用 | |
CN107496325A (zh) | 含牡丹精油、青瓜提取液和蜗牛原液的面膜及其制备方法 | |
CN106137916A (zh) | 一种祛痘控油美白的化妆品组合物及其应用 | |
CN104983646A (zh) | 夜用养护面膜液及其制备方法 | |
CN105193697A (zh) | 一种面膜组合物及其制备方法 | |
CN112826847A (zh) | 用于祛痘及淡化痘印的微针贴片及其制备方法 | |
CN111514036A (zh) | 一种提拉紧致抗衰老面膜及其制备方法 | |
CN111514055A (zh) | 一种具有抗炎修复功效的化妆品用多肽组合物颗粒剂 | |
CN112641637B (zh) | 一种抑制痤疮自发热吸水凝胶化的海藻纤维面膜 | |
KR102014979B1 (ko) | 생분해성 고분자와 황토가 결합되어 탄력성이 증진된 기능성 마스크팩 및 그의 제조방법 | |
CN106692012A (zh) | 一种提供营养的细胞修复液 | |
CN214343489U (zh) | 一种自发热吸水凝胶化的海藻纤维面膜 | |
CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
CN111419770A (zh) | 保湿修复型温感唤醒面膜及其制备方法 | |
CN101596310A (zh) | 一种用于创面修复的人工基底膜乳膏 | |
CN115282105A (zh) | 一种婴童护肤组合物及其制备方法 | |
CN112807268B (zh) | 一种源于原汁的无粘腻妆食同源芦荟胶及其制备方法 | |
CN109303710A (zh) | 一种新型皮肤紧致修护组合物、制剂及其制备方法 | |
CN108478463A (zh) | 含有红叶藻提取物的组合物及其在化妆品的应用 | |
CN108392442A (zh) | 含有欧囊链藻提取物的组合物及其在化妆品的应用 | |
CN114642623A (zh) | 一种皮肤抗菌修复功能液及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |